These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21334976)

  • 21. Therapeutics that directly increase SMN expression to treat spinal muscular atrophy.
    Shababi M; Mattis VB; Lorson CL
    Drug News Perspect; 2010 Oct; 23(8):475-82. PubMed ID: 21031163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smn deficiency causes neuritogenesis and neurogenesis defects in the retinal neurons of a mouse model of spinal muscular atrophy.
    Liu H; Beauvais A; Baker AN; Tsilfidis C; Kothary R
    Dev Neurobiol; 2011 Feb; 71(2):153-69. PubMed ID: 20862739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoring Bcl-x(L) levels benefits a mouse model of spinal muscular atrophy.
    Tsai LK; Tsai MS; Ting CH; Wang SH; Li H
    Neurobiol Dis; 2008 Sep; 31(3):361-7. PubMed ID: 18590823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
    Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
    J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression profiling in spinal muscular atrophy reveals an RNA binding protein deficit.
    Anderson KN; Baban D; Oliver PL; Potter A; Davies KE
    Neuromuscul Disord; 2004 Nov; 14(11):711-22. PubMed ID: 15482955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Animal models of spinal muscular atrophy.
    Schmid A; DiDonato CJ
    J Child Neurol; 2007 Aug; 22(8):1004-12. PubMed ID: 17761656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmission ratio distortion in the spinal muscular atrophy locus: data from 314 prenatal tests.
    Botta A; Tacconelli A; Bagni I; Giardina E; Bonifazi E; Pietropolli A; Clementi M; Novelli G
    Neurology; 2005 Nov; 65(10):1631-5. PubMed ID: 16301493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of SMN gene in Chinese children with spinal muscular atrophy].
    Liu WL; Li F; Ma HW; Li HY
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jul; 12(7):539-43. PubMed ID: 20637152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SMN and Gemins: 'we are family' … or are we?: insights into the partnership between Gemins and the spinal muscular atrophy disease protein SMN.
    Cauchi RJ
    Bioessays; 2010 Dec; 32(12):1077-89. PubMed ID: 20954180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High incidence of SMN1 gene deletion in Moroccan adult-onset spinal muscular atrophy patients.
    Bouhouche A; Benomar A; Birouk N; Bouslam N; Ouazzani R; Yahyaoui M; Chkili T
    J Neurol; 2003 Oct; 250(10):1209-13. PubMed ID: 14586604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spinal muscular atrophy: newborn and carrier screening.
    Prior TW
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):23-36, Table of Contents. PubMed ID: 20494255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refined characterization of the expression and stability of the SMN gene products.
    Vitte J; Fassier C; Tiziano FD; Dalard C; Soave S; Roblot N; Brahe C; Saugier-Veber P; Bonnefont JP; Melki J
    Am J Pathol; 2007 Oct; 171(4):1269-80. PubMed ID: 17717146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic strategies for the treatment of spinal muscular atrophy.
    Cherry JJ; Androphy EJ
    Future Med Chem; 2012 Sep; 4(13):1733-50. PubMed ID: 22924510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy.
    Passini MA; Bu J; Richards AM; Treleaven CM; Sullivan JA; O'Riordan CR; Scaria A; Kells AP; Samaranch L; San Sebastian W; Federici T; Fiandaca MS; Boulis NM; Bankiewicz KS; Shihabuddin LS; Cheng SH
    Hum Gene Ther; 2014 Jul; 25(7):619-30. PubMed ID: 24617515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Quantitative analysis of the genes determining spinal muscular atrophy].
    Nagymihály M; Herczegfalvi A; Tímár L; Karcagi V
    Ideggyogy Sz; 2009 Nov; 62(11-12):390-7. PubMed ID: 20025129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spinal muscular atrophy: going beyond the motor neuron.
    Hamilton G; Gillingwater TH
    Trends Mol Med; 2013 Jan; 19(1):40-50. PubMed ID: 23228902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spinal muscular atrophy: a clinical and research update.
    Markowitz JA; Singh P; Darras BT
    Pediatr Neurol; 2012 Jan; 46(1):1-12. PubMed ID: 22196485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic strategies for spinal muscular atrophy: SMN and beyond.
    Bowerman M; Becker CG; Yáñez-Muñoz RJ; Ning K; Wood MJA; Gillingwater TH; Talbot K;
    Dis Model Mech; 2017 Aug; 10(8):943-954. PubMed ID: 28768735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased stathmin expression ameliorates neuromuscular defects but fails to prolong survival in a mouse model of spinal muscular atrophy.
    Wen HL; Ting CH; Liu HC; Li H; Lin-Chao S
    Neurobiol Dis; 2013 Apr; 52():94-103. PubMed ID: 23268200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spinal muscular atrophy.
    Vitte J; Attali R; Warwar N; Gurt I; Melki J
    Adv Exp Med Biol; 2009; 652():237-46. PubMed ID: 20225030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.